Company profile: BioStem Technologies
1.1 - Company Overview
Company description
- Provider of placental-derived tissue allografts and regenerative medicine technologies, including VENDAJE and VENDAJE AC for protective covering of soft tissue wounds, VENDAJE OPTIC for ocular surface repair, and AmnioWrap2 to support natural healing. Offers BioREtain, a perinatal tissue processing method preserving growth factors and tissue structure, and Local MicroEnvironment Activation to promote tissue repair.
Products and services
- AmnioWrap2: A placental-derived allograft engineered as a protective covering for soft tissue wounds, designed to support the body’s natural healing process
- BioREtain: A proprietary processing method for manufacturing perinatal tissue allografts that preserves native tissue structure and maintains natural growth factors during fabrication
- Local MicroEnvironment Activation (LMA): A proprietary approach utilizing combinations of small molecules, cytokines, and growth factors to activate the local microenvironment and promote tissue repair.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BioStem Technologies
Olivo Labs
HQ: United States
Website
- Description: Provider of proprietary biomaterials technology advancing the dermatological field, including its pioneering XPLTM "Second Skin" technology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Olivo Labs company profile →
Artelon
HQ: United States
Website
- Description: Provider of bio-textile solutions for kinematic reinforcement of tendon and ligament reconstruction, developing synthetic materials for tissue reconstruction and restoring stability and motion. Products include FLEXBAND biomaterial and systems (Twist, Solo, Multi, FIX), FLEXBAND Plus, FLEXPATCH, Dynamic Matrix Technology used in over 60,000 implantations, and educational programs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Artelon company profile →
Humacyte
HQ: United States
Website
- Description: Provider of bioengineered vascular and anatomical conduit solutions, including the Human Acellular Vessel (HAV) in clinical trials for trauma repair and arteriovenous access; the LUNA200 bioengineering system for producing HAV; and the BioVascular Pancreas in preclinical studies for type 1 diabetes, delivering insulin-producing islets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Humacyte company profile →
Harbor MedTech
HQ: United States
Website
- Description: Provider of tissue regeneration products for chronic wounds, hernia and joint repair. Offers Architect, a stabilized collagen matrix for various chronic skin wounds; BPMatrix, a collagen patch for orthopedic soft tissue injuries such as tendon repairs; and BriDGE Technology, a patented method to create a stabilized collagen matrix that supports tissue regeneration, accelerates wound healing, and prevents infection.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Harbor MedTech company profile →
Meccellis Biotech
HQ: France
Website
- Description: Provider of biomaterials and tissue and cell engineering, creating biological implants in dialogue with surgeons. Products include CELLIS, a preservative-free dermal matrix for varied surgeries; CELLIS Breast, a porcine dermis matrix for breast reconstruction; and CELLIS Dental, a non-pyrogenic acellular membrane for dental soft tissue repair.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Meccellis Biotech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BioStem Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BioStem Technologies
2.2 - Growth funds investing in similar companies to BioStem Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BioStem Technologies
4.2 - Public trading comparable groups for BioStem Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →